troglitazone has been researched along with Rheumatism in 1 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
Excerpt | Relevance | Reference |
---|---|---|
"Impressic acid, 3α,11α-dihydroxylup-20(29)-en-28-oic acid, is a lupane-type triterpenoid isolated from Acanthopanax koreanum, which has been used as a Korean folk medicine for rheumatism, hepatitis, diabetes, and inflammatory disorders." | 3.77 | Effects of impressic acid from Acanthopanax koreanum on NF-κB and PPARγ activities. ( Kim, JA; Kim, YH; Song, SB; Yang, SY, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, JA | 1 |
Yang, SY | 1 |
Song, SB | 1 |
Kim, YH | 1 |
1 other study available for troglitazone and Rheumatism
Article | Year |
---|---|
Effects of impressic acid from Acanthopanax koreanum on NF-κB and PPARγ activities.
Topics: Bone Marrow Cells; Cell Survival; Chromans; Cytokines; Dendritic Cells; Dose-Response Relationship, | 2011 |